Leontios Pappas

机构：Harvard University, Massachusetts General Hospital · ORCID：0000-0002-0589-8265

发表论文 167 篇 · 总被引 777 次 · h-index 8

代表论文

• Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors (2025 · Annals of Oncology · 被引 63)
• Acquired On-Target Alterations Drive Clinical Resistance to p53-Y220C Reactivators (2026 · Cancer Discovery · 被引 6)
• Personalized Treatment Modalities for Rectal Cancer: Advances in Neoadjuvant Treatment (2025 · Journal of Clinical Medicine · 被引 2)
• Abstract B096: Immune and stromal features of durable complete response to radiation and dual immune checkpoint blockade in pancreatic cancer (2026 · Cancer Research)
• Tumor-directed therapy in HR+ Breast Cancer oligoprogression to mutant selective PI3K-alpha inhibitor plus fulvestrant (2026 · npj Breast Cancer)
• Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors (2026 · Figshare)